These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
737 related articles for article (PubMed ID: 17114237)
1. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Lin EY; Li JF; Gnatovskiy L; Deng Y; Zhu L; Grzesik DA; Qian H; Xue XN; Pollard JW Cancer Res; 2006 Dec; 66(23):11238-46. PubMed ID: 17114237 [TBL] [Abstract][Full Text] [Related]
2. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated macrophages press the angiogenic switch in breast cancer. Lin EY; Pollard JW Cancer Res; 2007 Jun; 67(11):5064-6. PubMed ID: 17545580 [TBL] [Abstract][Full Text] [Related]
4. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch. Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic switch as a molecular target of malignant tumors. Tanaka S; Sugimachi K; Yamashita Y; Shirabe K; Shimada M; Wands JR; Sugimachi K J Gastroenterol; 2003 Mar; 38 Suppl 15():93-7. PubMed ID: 12698880 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Liao D; Corle C; Seagroves TN; Johnson RS Cancer Res; 2007 Jan; 67(2):563-72. PubMed ID: 17234764 [TBL] [Abstract][Full Text] [Related]
7. Breast tumor cell TACE-shed MCSF promotes pro-angiogenic macrophages through NF-κB signaling. Rego SL; Helms RS; Dréau D Angiogenesis; 2014 Jul; 17(3):573-85. PubMed ID: 24197832 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype. Almog N; Ma L; Raychowdhury R; Schwager C; Erber R; Short S; Hlatky L; Vajkoczy P; Huber PE; Folkman J; Abdollahi A Cancer Res; 2009 Feb; 69(3):836-44. PubMed ID: 19176381 [TBL] [Abstract][Full Text] [Related]
9. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Gao D; Nolan DJ; Mellick AS; Bambino K; McDonnell K; Mittal V Science; 2008 Jan; 319(5860):195-8. PubMed ID: 18187653 [TBL] [Abstract][Full Text] [Related]
10. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development. Eichten A; Hyun WC; Coussens LM Cancer Res; 2007 Jun; 67(11):5211-20. PubMed ID: 17545601 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Lin EY; Li JF; Bricard G; Wang W; Deng Y; Sellers R; Porcelli SA; Pollard JW Mol Oncol; 2007 Dec; 1(3):288-302. PubMed ID: 18509509 [TBL] [Abstract][Full Text] [Related]
12. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Nozawa H; Chiu C; Hanahan D Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12493-8. PubMed ID: 16891410 [TBL] [Abstract][Full Text] [Related]
13. Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy. Zins K; Sioud M; Aharinejad S; Lucas T; Abraham D Methods Mol Biol; 2015; 1218():143-61. PubMed ID: 25319650 [TBL] [Abstract][Full Text] [Related]
14. Target validation using RNA interference in solid tumors. Aharinejad S; Sioud M; Lucas T; Abraham D Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715 [TBL] [Abstract][Full Text] [Related]
15. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Zins K; Abraham D; Sioud M; Aharinejad S Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development. Pyonteck SM; Gadea BB; Wang HW; Gocheva V; Hunter KE; Tang LH; Joyce JA Oncogene; 2012 Mar; 31(11):1459-67. PubMed ID: 21822305 [TBL] [Abstract][Full Text] [Related]
17. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. Carmi Y; Voronov E; Dotan S; Lahat N; Rahat MA; Fogel M; Huszar M; White MR; Dinarello CA; Apte RN J Immunol; 2009 Oct; 183(7):4705-14. PubMed ID: 19752225 [TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer. Persano L; Moserle L; Esposito G; Bronte V; Barbieri V; Iafrate M; Gardiman MP; Larghero P; Pfeffer U; Naschberger E; Stürzl M; Indraccolo S; Amadori A Carcinogenesis; 2009 May; 30(5):851-60. PubMed ID: 19237608 [TBL] [Abstract][Full Text] [Related]
19. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment. Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982 [TBL] [Abstract][Full Text] [Related]
20. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes. Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]